À¯ÀüÀÚ ÆíÁý ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±â¼úº°, Àü´Þ ¹æ¹ýº°, ¿ëµµº°, ¸ðµåº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Genome Editing Market Size, Share & Trends Analysis Report By Technology, By Delivery Method, By Application, By Mode, By End Use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1726231
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,194,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,325,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯ÀüÀÚ ÆíÁý ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è À¯ÀüÀÚ ÆíÁý ½ÃÀå ±Ô¸ð´Â 2030³â¿¡ 250¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â¿¡ °ÉÃÄ 16.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ Áøº¸ Áõ°¡, À¯ÀüüÇÐ »ê¾÷¿¡ ´ëÇÑ ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ Áõ°¡, À¯Àü ÁúȯÀÇ À¯º´·ü Áõ°¡, Ä¡·á ¹× Ä¡·á °³¼±ÀÇ Çʿ伺Àº ¼öÀÍ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ ÁøÈ­´Â ½ÃÀåÀÇ ¼öÀÍ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀÔ´Ï´Ù. Genomics¿Í New England BiolabÀº CRISPR À¯ÀüÀÚ º¯Çü µµ±¸ ¹× ½Ã¾à °³¹ß ¹× »ó¾÷È­¸¦ À§ÇØ Çù·ÂÇß½À´Ï´Ù.

À¯ÀüÀÚ º¯Çü µµ±¸ÀÇ Ä¡·á ¿¬±¸¿¡ ´ëÇÑ ÀÀ¿ëÀÌ ÁøÇàµÊ¿¡ µû¶ó ÀÓ»ó °Ë»ç¿¡ µé¾î°¡´Â ÷´Ü Ä¡·áÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚµéÀº CRISPR°ú °°Àº À¯ÀüÀÚ º¯Çü ÀåÄ¡°¡ ´Ù¾çÇÑ ¸¸¼º ÁúȯÀÇ ½Å¼ÓÇÑ ½ºÅ©¸®´× ¼Ö·ç¼ÇÀÌ µÉ ¼ö ÀÖ´Â °¡´É¼ºÀ» ޱ¸Çϰí ÀÖ½À´Ï´Ù.

À¯ÀüÀÚ ÆíÁý ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå À¯ÀüÀÚ ÆíÁý ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ±â¼úº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦5Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : Àü´Þ ¹æ¹ý ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦6Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ¿ëµµ ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦7Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ¸ðµå ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦8Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦9Àå À¯ÀüÀÚ ÆíÁý ½ÃÀå : Áö¿ªº°, ÃßÁ¤ ¹× ¿¹Ãø ºÐ¼®

Á¦10Àå °æÀï ±¸µµ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Genome Editing Market Growth & Trends:

The global genome editing market size is expected to reach USD 25.00 billion in 2030 and is projected to grow at a CAGR of 16.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing advancements in genome editing technology, the growing funding & investments in the genomics industry, the increasing prevalence of genetic disorders, and the need for improved treatments and therapies are major factors driving revenue growth.

The evolution of genome editing technologies is another contributing factor to drive revenue growth in the market. Most effective and accurate gene editing is now possible through the enhancement of new and advanced genome editing methods including CRISPR-Cas13,prime editing, and base editing, amongst others. This creates genome editing methods used more often in academic and medical contexts. For instance, in January 2020, ERS Genomics and New England Biolab collaborated to develop and commercialize CRISPR gene modification tools & reagents.

The increasing application of gene-modification tools in therapeutic research has resulted in the rising number of advanced therapeutics entering clinical trials. Furthermore, the use of artificial intelligence to advance the implementation of novel gene modification systems exhibits great potential for the technology developer. This is anticipated to greatly favor revenue generation in the foreseeable future. Research communities are exploring the potential of gene-modification instruments such as CRISPR as a potential fast screening solution for various chronic diseases. Such research programs are likely to benefit the market for genome editing in the coming years.

Genome Editing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Genome Editing Market Variables, Trends & Scope

Chapter 4. Genome Editing Market: Technology Estimates & Trend Analysis

Chapter 5. Genome Editing Market: Delivery Method Estimates & Trend Analysis

Chapter 6. Genome Editing Market: Application Estimates & Trend Analysis

Chapter 7. Genome Editing Market: Mode Estimates & Trend Analysis

Chapter 8. Genome Editing Market: End-Use Estimates & Trend Analysis

Chapter 9. Genome Editing Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â